51 reports

Report Scope: The key objectives of this study are to - Review the impact that diabetes is having on global health. This includes - - Review of diabetes as a disease. - Review of the epidemiology of diabetes. - Data and statistics by region. - Predictions of future incidence and prevalence of diabetes...

  • Antidiabetics
  • Medical Device
  • Diabetes
  • World
  • Medical Devices Sales
  • Diabetes Prevalence

World Antidiabetics

  • Antidiabetics
  • World
  • APAC
  • North America
  • Europe
  • Health Expenditure
  • Diabetes Prevalence

This study covers the world outlook for antidiabetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Antidiabetics
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for insulins and anti-diabetic hormones and synthetic substitute pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country...

  • Antidiabetics
  • Insulin
  • World
  • United States
  • Disposable Income
  • Gross Domestic Product

World Antidiabetics Diabetes Monitoring

  • Antidiabetics
  • World
  • Diabetes Prevalence
  • Health Expenditure

Egypt North Africa Pharmaceutical Recombinant Insulin Insulin Life Sciences Protein Therapy Antidiabetics

  • Insulin
  • Europe
  • Diabetes Prevalence
  • Mortality Rate

China Sichuan Austria New York Antidiabetics Managed Care

  • Insulin
  • World
  • Health Expenditure
  • Drug Approval

United States Diabetes Prevalence Antidiabetics Diabetes

  • Antidiabetics
  • United States
  • Europe
  • APAC
  • China
  • Diabetes Prevalence
  • Health Expenditure

World Insulin Antidiabetics

  • Pharmaceutical
  • Insulin
  • World

Canada Insulin Delivery Diabetes Care Insulin Antidiabetics Diabetes Monitoring Point Of Care Testing

  • Insulin
  • Insulin Delivery
  • Diabetes Care
  • Diabetes Monitoring
  • Canada
  • Diabetes Prevalence
  • Drug Approval

United Kingdom Canada Antidiabetics Insulin Delivery Diabetes Pharmacy

  • Diabetes
  • Insulin
  • Injectable Delivery
  • Europe
  • APAC
  • North America
  • Chronic Disease Prevalence
  • Diabetes Prevalence

India Karnataka Antidiabetics Monoclonal Antibody Protein Therapy Biopharmaceutical Antifungal Insulin Immunology Obesity Biosimilar Statins Oncology

  • Insulin
  • Recombinant Insulin
  • Indiana
  • Diabetes Prevalence
  • Drug Approval

World Medical Devices Sales Injectable Delivery Pharmaceutical Antidiabetics Medical Device Diabetes Care Diabetes Healthcare

  • Medical Device
  • Insulin
  • Healthcare
  • Indiana
  • Diabetes Prevalence
  • Health Expenditure

This study covers the latent demand outlook for insulins and anti-diabetic hormones and synthetic substitute pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each...

  • Antidiabetics
  • Insulin
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for insulins and anti-diabetic hormones and synthetic substitute pharmaceuticals across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city...

  • Antidiabetics
  • Insulin
  • India
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for insulins and anti-diabetic hormones and synthetic substitute pharmaceuticals across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions...

  • Antidiabetics
  • Insulin
  • China
  • Disposable Income
  • Purchasing Power Parity

Oramed World Urban Population Health Expenditure Insulin Antidiabetics

  • Insulin
  • World
  • APAC
  • Diabetes Prevalence
  • Health Expenditure

In the obese animal model, HM## was twice as effective as currently available drugs in weight loss and shown significant body-weight reduction when administered in combination with the anti-diabetic drug DPP-##.

  • Insulin
  • World

Denmark Pharmaceutical Hormone Biopharmaceutical Antidiabetics Obesity Diabetes

  • Insulin
  • World
  • Indiana
  • Health Expenditure
  • Overweight Prevalence

One Drop World Germany Pharmaceutical Antidiabetics Cardiovascular Disease Managed Care Dietary Supplement Mobile Application Diabetes Care Healthcare Hypertension Diabetes

  • Mobile Application
  • Smartphone
  • Biometrics
  • Application
  • Antidiabetics
  • Diabetes Care
  • World
  • United States
  • New York
  • Silicon Production
  • Diabetes Prevalence

United States North America Antidiabetics Diabetes Care Diabetes Therapy

  • Diagnostic Imaging
  • Insulin
  • Clinical Trial
  • Catheter
  • United States
  • World
  • North America
  • Medical Devices Sales

Recently, mechanistic studies revealed that compounds extracted from anti-diabetic TCM displayed beneficial effects in the treatment of diabetes and

  • Diabetes
  • Insulin
  • China
  • Labour Force
  • Industrial Production

World Health Expenditure Antidiabetics

  • Antidiabetics
  • World
  • APAC
  • Health Expenditure
  • Diabetes Prevalence

Are novel therapies set to revolutionise NASH? No drug therapies have been approved for patients with nonalcoholic steatohepatitis (NASH) but this could all change in the next 3-5 years. Four late-stage pipeline programmes are advancing through development, and 16 mid-stage pipeline programmes are also making progress. Which ones will...

  • Hormone
  • Digestive System Disorder
  • Antidiabetics
  • Specialty Hospital
  • United States

“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology ( Prevalence of Type 1 & 2 Diabetes) in the US market along with the associated economic burden and productivity loss. Diabetes...

  • Antidiabetics
  • Diabetes
  • Insulin
  • United States
  • Diabetes Prevalence

The global saffron market is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising product use in food applications as a flavoring and coloring agent will augment growth over the next nine years. The product is being employed in medical applications to treat dry skin, cough, and asthma....

  • Pharmaceutical
  • Dermatological Condition
  • Spice
  • Concrete Admixture
  • Antidiabetics
  • Analgesic
  • Skin Care
  • Fragrance
  • World
  • APAC
  • Europe
  • Middle East
  • Africa

LEO Pharma MediGene Sanofi Sanofi-Aventis Veregen Germany Land Berlin Drug Approval Health Provider Density Pharmaceutical Healthcare Antidiabetics

  • Pharmaceutical
  • Healthcare
  • Antidiabetics
  • Germany
  • Land Berlin
  • Drug Approval
  • Health Provider Density

The agreement enables Biocon to focus on the anti-diabetic and insulin market segment in Malaysia and Brunei.

  • Pharmaceutical
  • Healthcare
  • Insulin
  • Malaysia
  • Pharmaceutical Production
  • Spending On Medicines

The agreement enables Biocon to focus on the anti-diabetic and insulin market segment in Malaysia and Brunei.

  • Pharmaceutical
  • Insulin
  • Healthcare
  • India
  • Foreign Direct Investment
  • Prescription Drug Sales

Biovotion Europe United States Patient Monitoring Antidiabetics Multi Parameter Medical Monitoring Diabetes

  • Diabetes Monitoring
  • Clinical Trial
  • Antidiabetics
  • Switzerland
  • Europe
  • Diabetes Prevalence
  • Medical Devices Sales